Epilepsy Notes

A Welcome New Option in Epilepsy Therapy Clobazam was recently approved for seizures associated with Lennox-Gastaut syndrome. Dr. Andrew Wilner discusses the clinical role of the agent.
Experts And Viewpoints, January 2012
Optimal Contraception in Women with Epilepsy: Enter Facebook A new registry leverages social networking and the Web to collect valuable data on the safety and efficacy of contraceptives in women with epilepsy.
Experts And Viewpoints, November 2011
Which Antiepileptic Drugs Work Best? Dr. Andrew Wilner navigates the daunting list of antiepileptic options from which clinicians have to choose when managing seizures.
Experts And Viewpoints, October 2011
Valproic Acid: A Happy Accident, Again? Dr. Andrew Wilner discusses a new study exploring the potential role of valproic acid in glioblastoma.
Experts And Viewpoints, September 2011
Antiepileptic Drugs and Birth Defects Dr. Andrew Wilner discusses a recently published epidemiologic study evaluating the teratogenicity of 5 new antiepileptic agents.
Experts And Viewpoints, August 2011
Ezogabine: A New Drug for Seizure Control Dr. Andrew Wilner discusses the FDA's approval of ezogabine for partial seizure control. What role will the drug play in clinical practice?
Experts And Viewpoints, June 2011
Marijuana: A Viable Epilepsy Therapy? Dr. Andrew Wilner explores the evidence to date on marijuana as a potential treatment for epilepsy.
Experts And Viewpoints, June 2011
Dangers of Epilepsy: A Population Study A study finds disturbing links between epilepsy and violence, but the connection is not straightforward.
Experts And Viewpoints, April 2011
Managing Nonconvulsive Seizures in the PICU We have the technology to detect nonconvulsive seizures -- but how and when it should be used are unanswered questions.
Experts And Viewpoints, March 2011
Childhood-Onset Epilepsy Triples Risk for Death The implications of these high-quality findings are clear.
Experts And Viewpoints, March 2011
Follow the Path to Progress -- Walk for Epilepsy! Epilepsy Foundation's 5th Annual Walk aims to improve epilepsy diagnosis, prevention, social acceptability, and treatment.
Experts And Viewpoints, March 2011
New Epilepsy Guidelines: Are They Necessary? The American Academy of Neurology recently published a set of epilepsy care quality measures. But are they necessary?
Experts And Viewpoints, January 2011
A Gold Mine of Epilepsy Resources Dr. Andrew Wilner highlights new epilepsy treatments and information resources in honor of National Epilepsy Awareness Month.
Experts And Viewpoints, November 2010
Aseptic Meningitis From Lamotrigine -- A New Headache for People With Epilepsy? Dr. Andrew Wilner discusses the practical ramifications of the FDA's recent warning that lamotrigine may cause aseptic meningitis. But is the association less common than a lightning strike?
Experts And Viewpoints, September 2010
Epilepsy in 2010 -- Does Stigma Still Exist? Dr. Andrew Wilner explores the state of epilepsy stigma. Have we made any progress?
Experts And Viewpoints, July 2010
Progress in Epilepsy: An Interview With Chrysostomos P. Panayiotopoulos, MD Dr. Chrysostomos P. Panayiotopoulos, one of the world's leading experts on epilepsy, speaks with Dr. Andrew Wilner on the progress of epilepsy care.
Experts And Viewpoints, July 2010
Epilepsy in Haiti After the Earthquake: An Update Five months later, Dr. Andrew Wilner re-examines the state of epilepsy and medical care in Haiti.
Experts And Viewpoints, June 2010
Thalamic Stimulation: New Approach to Treatment of Epilepsy Dr. Andrew Wilner discusses the safety, efficacy, and potential use of bilateral thalamic stimulation in the treatment of epilepsy.
Experts And Viewpoints, April 2010
A Genetic Panel With That Dilantin Level, Please? Dr. Andrew Wilner explores the evolving role of genetic testing in diagnosing and managing epilepsy.
Experts And Viewpoints, March 2010
Earthquake Highlights Problem of Global Epilepsy Dr. Andrew Wilner discusses the severe lack of epilepsy resources in post-earthquake Haiti.
Experts And Viewpoints, March 2010